Subunit Influenza Vaccine (Tasly Jinna Biotech)

流感病毒亚单位疫苗（天士力金纳）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSubunit Influenza Vaccine (Tasly Jinna Biotech)
Drug Alias Nameinactivated influenza vaccine (intramuscular/subcutaneous, influenza)Fuluoke孚洛克
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2010/04/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTianjin Tasly Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGazo Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A